Nasopharyngeal Cancer Doctors Abroad — Page 2

Assistant Professor Tahsin Ozadli has managed over 1,100 cancer cases at Valued Med Hub Hospitals using evidence-based protocols.

• Trained at the Dr Abdurrahman Yurtaslan Ankara Oncology Hospital, a major regional cancer centre
• Coordinates multidisciplinary care for oesophageal and upper respiratory tract tumours
• Highly active in clinical research with a dedicated Google Scholar profile of publications
• Practices at Valued Med Hub Hospitals, focusing on personalised medical oncology plans

Associate Professor Nail Paksoy is an ESMO-certified medical oncologist specialising in comprehensive cancer care and innovative drug therapies.

• Board-certified by the European Society for Medical Oncology (ESMO) in Paris
• Experienced subinvestigator in international clinical trials for immunotherapy and targeted agents
• Uses PRRT therapy – targeted radiation that destroys neuroendocrine tumour cells with precision
• Serves as Associate Professor at Medipol University, leading the next generation of oncologists
• Published over 40 research papers on treatment efficacy and patient survival outcomes

Professor Mustafa Serkan Alemdar is a medical oncology specialist at Medical Park Antalya with deep expertise in managing complex head and neck malignancies.

• Trained at Akdeniz University in both internal medicine and medical oncology
• Focuses on targeted therapy and immunotherapy for nasopharyngeal cancer cases
• Served at Antalya Training and Research Hospital, a major regional specialist centre
• Member of the Turkish Society of Medical Oncology
• Experienced in managing chemotherapy protocols for advanced-stage cancer patients

Professor Ercan Ozden is a specialist medical oncologist at VM Medical Park Pendik who trained at Istanbul University's prestigious English Medical Programme.

• Treats nasopharyngeal cancer using targeted drug therapies and chemical-based treatments
• Subspecialised in medical oncology at Kocaeli University's Faculty of Medicine
• Completed a rigorous internal medicine residency at Cerrahpasa Hospital
• Manages complex chemotherapy regimes to shrink tumours before further treatment
• Focuses on evidence-based protocols to manage side effects and improve patient comfort

Dr. Irfan Cicin is a Professor of Medical Oncology at the Trakya University Faculty of Medicine (2015–present). He has over 20 years of medical oncology experience and has held academic roles since 2010.

Education: MD, Istanbul University – Cerrahpaşa (1991–1997). Residency in Internal Medicine, Trakya University (1997–2002). Fellowship in Medical Oncology, Trakya University (2002–2004).

Practice: Medical Oncologist, Trakya University (2005–2008). Medical Oncologist, Elazığ Training and Research Hospital (2008–2010). Associate Professor of Medical Oncology, Trakya University (2010–2015). He previously served as a physician in the Turkish Air Force at Etimesgut Military Hospital (2004–2005).

Assoc. Prof. Atakan Topçu, M.D., is a medical oncologist at Medipol University and Medipol Acıbadem Regional Hospital. He treats solid tumors, including lung, breast, colorectal, gastric, and neuroendocrine cancers. His work also covers targeted therapies, immunotherapy, geriatric oncology, and cancer-related malnutrition, cachexia, and sarcopenia.

He has authored more than 50 peer-reviewed papers. Recent work includes a 2024 Frontiers in Medicine study on geriatric syndromes and a 2023 Future Oncology paper on sarcopenia and anxiety in lung cancer. He has also published on the CONUT score in breast cancer and on malnutrition in HER2-negative metastatic gastric cancer.

Dr. Topçu serves on the Editorial Board of BMC Cancer. He is a member of the Turkish Society of Medical Oncology, ESMO, and the Turkish Geriatrics Society. Education and training: M.D., Uludağ University; residency in Internal Medicine, Marmara University; fellowship in Medical Oncology, Bezmialem Vakıf University.

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at İstinye University, Liv Hospital Topkapı (2025–present). He previously served as Associate Professor and Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital (2023–2025). He was also a Medical Oncologist there (2018–2021).

He has been a member of ASCO and the Turkish Society of Medical Oncology since 2018. He is the author or co-author of 19 peer-reviewed international papers on colon, breast, gastric, pancreatic, lung, thyroid, sarcoma, and colorectal cancers.

Notable works include a multicentre study on stage IIB colon cancer survival (Journal of Chemotherapy). He also studied the De Ritis ratio for lung metastasis in testicular cancer (Current Urology). His prognostic studies used PET/CT, MSI, lymph node ratio, and metabolic tumor volume.